SCRIBE

Welcome to the Brand page for “SCRIBE”, which is offered here for Biotechnology and pharmaceutical research for others, identifying important genes regulated by rna-protein interactions, developing assays to identify small molecule drugs to alter the interactions; and designing and developing drugs as potential therapeutic agents;.

Its status is currently believed to be active. Its class is unavailable. “SCRIBE” is believed to be currently owned by “Message Pharmaceuticals, Inc.”


Owner:
MESSAGE PHARMACEUTICALS, INC.
Owner Details
Description:
Biotechnology and pharmaceutical research for others, identifying important genes regulated by RNA-protein interactions, developing assays to identify small molecule drugs to alter the interactions; and designing and developing drugs as potential therapeutic agents;
Categories: BIOTECHNOLOGY PHARMACEUTICAL RESEARCH